Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this FDA Warning Letter was issued to McKesson Corporation, a major pharmaceutical distributor and healthcare company, on February 7, 2019. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning pertains to products classified as "Other," suggesting it may fall outside standard pharmaceutical or medical device categories. Additional details regarding the specific regulatory violations and the issuing FDA office would be needed to fully characterize the compliance issues identified.